Updated on 28 November 2013
Which are the emerging technologies in vaccine manufacturing?
Globally, the vaccine industry is diverging in terms of technology platforms. Focus has shifted towards innovative approaches to solve complex diseases like cancer, HIV, TB, malaria, dengue, and others. Independent of these newer initiatives, the vaccine industry as a whole continues to look for ways to increase productivity (through robustness, capacity increase, etc) and reduce cost. Here, we see increased adaptation of single use technologies particularly in upstream processing and formulation and finish/fill of vaccines.
What are the challenges faced by a vaccine manufacturer in Asia?
Firstly, Asia has always been known for low labor cost, however, the situation is changing fast. Secondly, getting skilled manpower in Asia is challenging. Also, there is lack of awareness among students to pursue career in biotechnology. There is general perception that life science means only research and development, which in reality is a small part of the whole process. Besides, Asia is competitive for high volume, low cost manufacturing. But having a readily available site that gives low cost manufacturing is not enough. There are several other issues involved in vaccine development that need to be addressed by a country, for instance security of supply chain, availability of skilled manpower, regulatory compliance, and smooth availability of resources.